Abstract
In March, 2020, the USA watched anxiously as the number of COVID-19 cases rose throughout the country. Yale New Haven Hospital, a tertiary care centre in Connecticut that is less than 80 miles east of New York city, swiftly planned for a large surge in patient numbers. Preliminary reports described frequent and varied neurological complications of COVID-19 (appendix p 1).1,2 In anticipation, the Yale New Haven Hospital neurology department created a subspecialty consult service led by a neuroinfectious disease specialist, to diagnose and treat an expected wave of patients with novel neurological issues.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
